Clinical Trial

National Multicentre Study on Lipid Profile in Noonan Syndrome and Related Disorders: Trends by Age, Gender and Genotype

Recruiting
View on ClinicalTrials.gov →
Summary
RASopathies, including Noonan syndrome, involve dysmorphisms, metabolic alterations, and an unfavorable lipid profile. This study investigates lipid and glucose metabolism to improve patient care.
Trial Details
NCT Number NCT07464821
Lead Sponsor IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions RASopathies, Noonan Syndrome
Enrollment 200 participants
Start Date 2025-02-26
Primary Completion 2027-02-26 (estimated)
Study Completion 2027-04-26 (estimated)
Updated on ClinicalTrials.gov 2026-03-11